bromocriptine has been researched along with reserpine in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (58.06) | 18.7374 |
| 1990's | 18 (29.03) | 18.2507 |
| 2000's | 5 (8.06) | 29.6817 |
| 2010's | 3 (4.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bo, P; Savoldi, F; Tartara, A | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Asper, H; Bürki, HR; Ruch, W; Züger, PE | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Saiani, L; Spano, PF; Tonon, G; Trabucchi, M | 1 |
| Bürki, HR; Jaton, AL; Loew, DM; Vigouret, JM; Züger, PE | 1 |
| Briner, U; Doepfner, W; Flückiger, E; Kovacs, E; Marbach, P; Wagner, HR | 1 |
| Boissier, JR; Chermat, R; Puech, AJ; Simon, P | 1 |
| Johnels, B; Steg, G; Ungerstedt, U | 1 |
| Horowski, R | 1 |
| Carminati, R; Cocchi, D; Locatelli, V; Müller, EE | 1 |
| Shuster, S; Thody, AJ | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Peterson, MR; Robertson, HA; Worth, GG | 1 |
| Carlsson, A; Carlsson, ML; Svensson, A | 1 |
| Helton, DR; Modlin, DL; Williams, PD | 1 |
| Dutt, A; Juneja, HS | 1 |
| Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S | 1 |
| Hosseini-Nia, T; Owji, AA; Zarrindast, MR | 1 |
| Minaian, A; Zarrindast, MR | 1 |
| Eliassi, A; Zarrindast, MR | 1 |
| Andén, NE; Casas, M; Ferré, S; Grabowska-Andén, M; Herrera-Marschitz, M; Ungerstedt, U | 2 |
| Hayashi, H; Mercado-Asis, LB; Miura, K; Murayama, M; Yamakita, N; Yasuda, K | 1 |
| Shahed-Dirin, K; Zarrindast, MR | 1 |
| George, SR; Kertesz, M | 1 |
| Tissari, AH | 1 |
| Casey, DE | 1 |
| Hara, T; Kishimoto, O; Mizuki, Y; Soeda, K; Ushijima, I; Yamada, M | 1 |
| Hashizume, M; Jackson, DM; Ross, SB | 1 |
| Mizuki, Y; Ushijima, I; Yamada, M | 1 |
| George, SR; Haas, DA | 1 |
| Hirose, A; Ohno, Y; Sasa, M; Takaori, S | 1 |
| Cubeddu, LX; Hoffmann, IS; Talmaciu, RK | 1 |
| Kinouchi, T; Shimizu, N; Takeda, F; Yoshida, H | 1 |
| Hatala, MA; Powers, CA | 1 |
| Cocchi, D; Craveri, A; Landi, G; Mailland, F; Masu, AM; Müller, EE; Poli, M | 1 |
| Hashizume, M; Jackson, DM | 1 |
| Benedetti, M; Bernardi, G; Calabresi, P; Mercuri, NB | 1 |
| Powers, CA | 1 |
| Jackson, DM; Jenkins, OF | 2 |
| Burch, WM | 1 |
| Jenner, P; Marsden, CD; Reavill, C | 1 |
| Ageel, AM; Parmar, NS; Tariq, M | 1 |
| Aflalo, L; Glick, SM; Levy, J; Liel, Y; Marbach, M | 1 |
| Johnels, B; Steg, G | 1 |
| Johnels, B | 1 |
| Rauca, C; Schröder, H | 1 |
| Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M | 1 |
| Clemens, JA; Okimura, T; Smalstig, EB | 1 |
| Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA | 1 |
| Ichihara, K; Kamei, H; Mizukoshi, K; Nagasaka, M; Okumura, K | 1 |
| Kralj, M; Pipan, N | 1 |
| Fukuzaki, K; Kamenosono, T; Nagata, R | 1 |
5 review(s) available for bromocriptine and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
Topics: Age Factors; Animals; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Haplorhini; Humans; Levodopa; Parasympatholytics; Reserpine; Risk | 1985 |
[Drug and radiotherapy of pituitary tumors].
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Reserpine; Valproic Acid | 1986 |
Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Dextroamphetamine; Drug Interactions; Fluoxetine; Humans; Methyltyrosines; Mice; Motor Activity; Nialamide; Nomifensine; Nucleus Accumbens; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1985 |
Cushing's disease. A review.
Topics: Adenoma; Adolescent; Adrenalectomy; Adult; Animals; Bromocriptine; Child; Combined Modality Therapy; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; Male; Microsurgery; Middle Aged; Pituitary Neoplasms; Prognosis; Radiotherapy; Recurrence; Reserpine; Sella Turcica; Valproic Acid | 1985 |
1 trial(s) available for bromocriptine and reserpine
| Article | Year |
|---|---|
Prolactin lowering effect of dihydroergokryptine in rat and in man.
Topics: Adult; Animals; Bromocriptine; Cimetidine; Dihydroergotoxine; Female; Humans; Male; Prolactin; Random Allocation; Rats; Rats, Inbred Strains; Reserpine; Sulpiride | 1986 |
56 other study(ies) available for bromocriptine and reserpine
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Antagonism between dopaminergic and neuroleptic drugs. I. Acute administration.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arousal; Bromocriptine; Central Nervous System; Chlorpromazine; Dibenzothiazepines; Electroencephalography; Haloperidol; Neurotransmitter Agents; Piribedil; Rabbits; Reserpine | 1979 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin | 1978 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Bromocriptine; Caudate Nucleus; Cyclic AMP; Dopamine; Haloperidol; Male; Rats; Receptors, Dopamine; Reserpine; Substantia Nigra | 1979 |
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Chemical Phenomena; Chemistry; Dihydroergotoxine; Electroencephalography; Ergolines; Humans; Locomotion; Male; Mice; Morphine; Movement Disorders; Rabbits; Rats; Receptors, Dopamine; Reserpine; Sleep; Stereotyped Behavior | 1978 |
Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Embryo Implantation; Ergolines; Female; Lactation; Methyltyrosines; Pregnancy; Prolactin; Rats; Reserpine; Secretory Rate | 1978 |
Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
Topics: Animals; Behavior, Animal; Body Temperature; Bromocriptine; Catalepsy; Drug Interactions; Ergolines; Ergotamines; Humans; Male; Mice; Motor Activity; Prochlorperazine; Reserpine; Social Environment; Stereotyped Behavior | 1977 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Dopamine; Drug Interactions; Ergot Alkaloids; Female; Lisuride; Lysergic Acid Diethylamide; Methyltyrosines; Mice; Reserpine; Sulpiride | 1978 |
Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
Topics: Animals; Bromocriptine; Ergolines; Female; Male; Metergoline; Pituitary Gland, Anterior; Prolactin; Quipazine; Radioimmunoassay; Rats; Reserpine; Time Factors | 1978 |
Sebum secretion after drugs which affect melanocyte-stimulating hormone secretion.
Topics: Animals; Bromocriptine; Melanocyte-Stimulating Hormones; Rats; Reserpine; Sebum; Trifluoperazine | 1977 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Dopamine Agents; Drug Synergism; Indoles; Male; Methyltyrosines; Mice; Motor Activity; Phenanthridines; Receptors, Dopamine D1; Reserpine | 1992 |
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Biogenic Monoamines; Bromocriptine; Dizocilpine Maleate; Dopamine Agents; Dopamine D2 Receptor Antagonists; Male; Methyltyrosines; Mice; Motor Activity; N-Methylaspartate; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Salicylamides; Tyrosine 3-Monooxygenase | 1992 |
Behavioral characterization of the new potent nonselective dopamine agonist pergolide.
Topics: Analgesics; Animals; Avoidance Learning; Behavior, Animal; Body Temperature; Bromocriptine; Dogs; Female; Male; Mice; Motor Activity; Neuromuscular Junction; Oxotremorine; Pergolide; Postural Balance; Rats; Reserpine; Salivation; Seizures; Sleep; Time Factors | 1992 |
Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Hypothalamus; In Vitro Techniques; Male; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Rats; Reserpine | 1992 |
Metastasis and neuroendocrine system in stressed mice.
Topics: Animals; Bromocriptine; Carcinoma; Female; Guanethidine; Lung Neoplasms; Mice; Mitotane; Naltrexone; Neoplasm Metastasis; Neuroimmunomodulation; Reserpine; Stress, Psychological | 1992 |
Evaluation of dopamine receptor involvement in rat feeding behaviour.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Feeding Behavior; Male; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Serotonin Antagonists | 1991 |
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming | 1991 |
Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Male; Methyltyrosines; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Indoles; Male; Mice; Motor Activity; Phenanthridines; Phenylisopropyladenosine; Receptors, Dopamine; Receptors, Dopamine D2; Reserpine; Sulpiride | 1991 |
Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bromocriptine; Caffeine; Dopamine; Male; Mice; Motor Activity; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Synapses; Theophylline; Xanthines | 1991 |
Reduction of pituitary tumor size with clinical and biochemical improvement with bromocriptine in a normoprolactinemic Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Reserpine | 1990 |
Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Methyltyrosines; Mice; Pimozide; Receptors, Dopamine; Reserpine; Sulpiride | 1990 |
Biphasic changes in anterior pituitary Met-enkephalin concentration following reserpine treatment.
Topics: Animals; Bromocriptine; Enkephalin, Methionine; Haloperidol; Injections, Intraperitoneal; Injections, Intraventricular; Male; Methoxamine; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Reserpine; Time Factors | 1988 |
Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
Topics: Animals; Apomorphine; Bromocriptine; Bucladesine; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Ouabain; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reference Values; Reserpine; Synaptosomes | 1988 |
Effects of age on behavioral responses to dopamine agonists in the rat.
Topics: Aging; alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine; Male; Methyltyrosines; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior; Tyrosine 3-Monooxygenase; Yawning | 1987 |
Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Bromocriptine; Drug Interactions; In Vitro Techniques; Male; Methyltyrosines; Mice; Motor Activity; Reserpine; Tyrosine 3-Monooxygenase | 1988 |
The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepines; Bromocriptine; Male; Methyltyrosines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Tyrosine 3-Monooxygenase; Yawning | 1988 |
Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus.
Topics: Adrenergic alpha-Agonists; Animals; Bromocriptine; Clonidine; Corticotropin-Releasing Hormone; Dopamine Agents; Epinephrine; Haloperidol; Hydroxydopamines; Hypothalamus; Male; Methoxamine; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reserpine | 1988 |
Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
Topics: Animals; Bromocriptine; Cats; Caudate Nucleus; Dopamine Agents; Droxidopa; Iontophoresis; Locus Coeruleus; Neural Pathways; Neurons; Norepinephrine; Reserpine; Serine | 1988 |
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Topics: Acetylcholine; alpha-Methyltyrosine; Animals; Apomorphine; Bromocriptine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Ergolines; Haloperidol; In Vitro Techniques; Methyltyrosines; Neurotransmitter Uptake Inhibitors; Nomifensine; Quinpirole; Rabbits; Receptors, Dopamine; Reserpine | 1986 |
Dopaminergic regulation of the estrogen-induced glandular kallikrein in the rat anterior pituitary.
Topics: Animals; Bromocriptine; Dopamine; Estradiol; Female; Haloperidol; Kallikreins; Peptide Hydrolases; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Reserpine; Synaptic Transmission | 1986 |
Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Bromocriptine; Dopamine; Drug Interactions; Male; Mice; Motor Activity; Receptors, Dopamine; Reserpine | 1986 |
Depletion of catecholamines reveals inhibitory effects of bromocryptine and lysuride on neostriatal neurones recorded intracellularly in vitro.
Topics: Animals; Bromocriptine; Catecholamines; Corpus Striatum; Electrodes; Ergolines; In Vitro Techniques; Lisuride; Male; Membrane Potentials; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Substantia Nigra | 1988 |
Dopaminergic regulation of glandular kallikrein in the intermediate lobe of the rat pituitary.
Topics: Animals; Bromocriptine; Dopamine; Haloperidol; Kallikreins; Kinetics; Male; Pituitary Gland; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains; Reserpine | 1986 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
Metabolite involvement in bromocriptine-induced circling behaviour in rodents.
Topics: Amphetamine; Animals; Apomorphine; Biotransformation; Bromocriptine; Desipramine; Female; Hydroxydopamines; Male; Medial Forebrain Bundle; Methyltyrosines; Mice; Motor Activity; Nomifensine; Paralysis; Proadifen; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Reserpine; Sleep; Zoxazolamine | 1980 |
Effect of bromocriptine, a dopamine receptor agonist, on the experimentally induced gastric ulcers in albino rats.
Topics: Animals; Aspirin; Bromocriptine; Female; Gastric Mucosa; Male; Phenylbutazone; Rats; Rats, Inbred Strains; Reserpine; Stomach Ulcer | 1984 |
Interaction of estrogen receptors with drugs that affect prolactin secretion.
Topics: Animals; Binding, Competitive; Bromocriptine; Estradiol; Female; Lisuride; Prolactin; Rats; Receptors, Estrogen; Reserpine | 1982 |
A mechanographic method for measurement of locomotor activity in rats. Effects of dopaminergic drugs and electric stimulation of the brainstem.
Topics: Animals; Apomorphine; Brain Stem; Bromocriptine; Dose-Response Relationship, Drug; Electric Stimulation; Locomotion; Male; Motor Activity; Neurophysiology; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine | 1982 |
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei | 1982 |
Effect of BCH 325 (Pro-D-Phe-Pro-Gly) on central dopaminergic functions.
Topics: Amino Acid Sequence; Animals; Apomorphine; Bromocriptine; Dopamine; Endorphins; Female; In Vitro Techniques; Molecular Sequence Data; Motor Activity; Nucleus Accumbens; Peptide Fragments; Potassium; Psychotropic Drugs; Rats; Rats, Wistar; Reserpine; Stimulation, Chemical; Synaptic Transmission; Yawning | 1995 |
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting | 1993 |
Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
Topics: Administration, Oral; Animals; Bromocriptine; Corpus Striatum; Injections, Intraperitoneal; Male; Oxidopamine; Pergolide; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine; Stereotyped Behavior; Substantia Nigra | 1993 |
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1993 |
Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Lisuride; Male; Rats; Rats, Wistar; Reserpine; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics | 1998 |
Accumulation of membranes and photoreceptor degeneration in mouse retina.
Topics: Animals; Apoptosis; Bromocriptine; Light; Mice; Organelles; Phagocytosis; Photoreceptor Cells, Vertebrate; Reserpine; Retinal Degeneration; Rod Cell Outer Segment | 1998 |
Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Catalepsy; Dopamine Agonists; Indoles; Macaca fascicularis; Male; Mice; Oxidopamine; Parkinsonian Disorders; Rats; Reserpine; Tremor | 2000 |